naion glp-1 news 💉 Optometrists are warning drugs may pose these types of rare risks 💉 ⬇️ Details in comments GLP-1 RA Weight Loss Drugs

This is why understanding the difference between research-grade and pharmaceutical-grade peptides matters so much when sourcing internationally

Whilst metreleptin monotherapy supports weight loss in obese individuals, it is not clinically meaningful with a mean 1.5 kg additional weight loss over 24 weeks noted in a previous trial [87]

9.4%), decreased appetite (5.8%, 12.3%, 17.1% vs

Other data suggest weight loss may approach the 30% range, which would place retatrutide among the most powerful weight-loss therapies studied so far

( Epub 2017 Oct 26 PMID: 29072533 ) Sodhi M, Rezaeianzadeh R, Kezouh A, Etminan M (2023) Risk of gastrointestinal adverse events associated with glucagon-like peptide-1 receptor agonists for weight loss

2008;34(Suppl 2):S73-S77